User Auth Test Page

Expansion Of PrEP Use Reportedly Stagnating In US

NBC Out (3/18, Ryan) reported, “A decade into the era of the HIV prevention pill, called PrEP, efforts to leverage its heralded power to curb new infections have stagnated in the United States,” and “this shortfall is a key reason the nation lags far behi...

Full Article
Most Children In US Virgin Islands Had Dengue, Making Them Vaccine Eligible, Research Finds

Healio (3/17, Weldon) reported that investigators “estimated that more than half of children aged 9 to 13 in the U.S. Virgin Islands have been previously infected with dengue virus, making them eligible for vaccination, according to findings published in...

Full Article
Burundi Declares Vaccine-Linked Polio Outbreak

The AP (3/17, Kang) reported Burundi health officials on Friday “declared an outbreak of polio linked to the vaccine” after the disease was “diagnosed in an unvaccinated four-year-old child...and in two other children who were contacts of the child,” mark...

Full Article
Malawi Fears Cyclone Freddy Could Worsen Cholera Outbreak

Reuters (3/17, Chagara) reported that people in Malawi are fearful that the very intense tropical cyclone Freddy will worsen the country’s existing cholera outbreak, just after Malawi appeared to have gotten the outbreak under control and was seeing a dec...

Full Article
Panel Of Expert Advisers To FDA Endorse Paxlovid As Treatment For COVID-19

The New York Times (3/16, Zimmer, Jewett, Mandavilli) reports, “A panel of expert advisers to the Food and Drug Administration on Thursday endorsed Paxlovid as a treatment for adults with Covid who are at high risk for progression to severe illness.” The...

Full Article
Cases Of Babesiosis More Than Doubled In Northeast Between 2011, 2019

The New York Times (3/16, Anthes) reports, “Cases of a tick-borne disease, called babesiosis, more than doubled in some Northeastern states between 2011 and 2019, researchers from the Centers for Disease Control and Prevention reported on Thursday.” Babes...

Full Article
“Mixed Duration” Or 90-Day Supply Of Chronic HBV Treatments Tied To Increased Patient Adherence, Research Indicates

Healio (3/16, Stulpin) reports, “Being prescribed a 90-day or a ‘mixed duration’ supply of entecavir or tenofovir disoproxil fumarate was associated with higher fill rates among commercially insured patients with chronic hepatitis B, researchers found.” R...

Full Article
FDA Says EUA For Pfizer COVID-19 Pill For Adolescents Will Remain Even After Full Approval For Adults

Reuters (3/16, Leo, Mandowara, Erman) reports that the FDA “said on Thursday the current emergency use authorization for Pfizer’s COVID-19 antiviral pill for high-risk adolescents will continue to remain in effect even if it receives full approval for use...

Full Article
Creating a Culture of Wellness in the Laboratory: Tips for Getting Started

Abstract Not Available

Full Article
No Association Between COVID-19 Antiviral Drug, Illness Rebound, FDA Report Says

ABC News (3/15, Flaherty, Westman) reports an FDA “analysis did not find a clear association between the COVID-19 antiviral drug Paxlovid [nirmatrelvir/ritonavir] and illness rebound, the FDA said in a new report.” Rebound rates are roughly “the same in p...

Full Article
J&J’s Experimental Dengue Drug Shows Promise In Early Research Involving Animals, Data Suggest

Reuters (3/15, Steenhuysen) reports an experimental drug JNJ-1802 “for dengue developed by Johnson & Johnson proved effective against all four types of the virus in mice and prevented infection from two types in monkeys, according to data published on Wed...

Full Article
Mozambique Sees Record Increase In Cholera Cases As Malawi Sees Decline

Reuters (3/15, Mahobe, Satija) reports, “Mozambique recorded an increase in the number of cholera cases in the last few weeks, the World Health Organization said on Wednesday, even as many other African countries reported a decline.” Meanwhile, “Mozambiqu...

Full Article
Monoclonal Antibody Treatments Protective Against RSV Infection Among Vulnerable Infants, Meta-Analysis Indicates

Infectious Disease Advisor (3/15, Nye) reports, “Results of a systematic review and network meta-analysis published in JAMA Network Open suggest that treatment with [monoclonal antibody treatments] motavizumab, nirsevimab, or palivizumab is significantly...

Full Article
President Biden Discusses Administration’s Plans To Lower Drug Costs

The AP (3/15, Seitz, Miller) reports that on Wednesday, President Biden “said his administration was focused ‘intensely’ on lowering health care costs.” Speaking in Las Vegas, Biden discussed how the Administration is rolling out provisions in the Inflati...

Full Article
FDA Grants Pfizer’s Bivalent COVID-19 Vaccine Emergency Approval As Booster In Children Aged Six Months To Four Years

Bloomberg (3/14, Cattan) reports Pfizer’s “bivalent shot for Covid-19 has received emergency approval to be used as a booster in some infants and toddlers.” Kids “between six months and four years old can receive the Pfizer-BioNTech SE shot at least two m...

Full Article
Russia’s Invasion Of Ukraine Worsens Spread Of HIV In Region, Studies Suggest

Healio (3/14, Feller) reports, “Russia’s 2022 invasion of Ukraine has worsened the spread of HIV in the region as thousands of war refugees migrate to neighboring countries, according to two studies.” While “most are receiving adequate care, the high numb...

Full Article
Malawi Faces Increased Risk Of Cholera Outbreak Following Heavy Rains From Cyclone

Bloomberg (3/14, Kew) reports, “Malawi, already having battled its worst-ever cholera outbreak this year, faces renewed risk of the water-borne diarrheal disease after heavy rains from a tropical cyclone damaged power supplies and other infrastructure.”

Full Article
FDA Staff Say Trial Data Support Use Of Pfizer’s Nirmatrelvir/Ritonavir In Adults At High Risk For Severe COVID-19

Reuters (3/14, Mandowara, Leo) reports FDA “staff reviewers said on Tuesday data from Pfizer Inc’s COVID-19 drug trials support its use in adults at high risk of progressing to severe disease, bringing the pill closer to a full approval.” The agency “made...

Full Article
Drug Developer Plans To Proceed With Late-Stage Trial Of COVID-19 Drug After FDA Declines Authorization

Reuters (3/14, Satija) reports that on Tuesday, Veru Inc “said it plans to proceed with a late-stage trial of its COVID-19 pill, weeks after the” FDA “declined to authorize the oral drug to treat high-risk patients hospitalized with COVID-19.” The company...

Full Article
PEPFAR Has Delivered Treatment To Over 20 Million People With HIV Since Its Inception, Report Says

The New York Times (3/14, Mandavilli) says, “In the 20 years since its inception, the President’s Emergency Plan for AIDS Relief (PEPFAR) has delivered lifesaving treatment to more than 20 million people in 54 countries, the most successful global health...

Full Article

Request a Call from Customer Relations

Name *
Topic *
Phone Number *
Scheduled Date *
Scheduled Time *
Customer Id

First Name *
Last Name *
Email *
Customer ID

Expansion Of PrEP Use Reportedly Stagnating In US

Most Children In US Virgin Islands Had Dengue, Making Them Vaccine Eligible, Research Finds

Burundi Declares Vaccine-Linked Polio Outbreak

Malawi Fears Cyclone Freddy Could Worsen Cholera Outbreak

Panel Of Expert Advisers To FDA Endorse Paxlovid As Treatment For COVID-19

Cases Of Babesiosis More Than Doubled In Northeast Between 2011, 2019

“Mixed Duration” Or 90-Day Supply Of Chronic HBV Treatments Tied To Increased Patient Adherence, Research Indicates

FDA Says EUA For Pfizer COVID-19 Pill For Adolescents Will Remain Even After Full Approval For Adults

Creating a Culture of Wellness in the Laboratory: Tips for Getting Started

No Association Between COVID-19 Antiviral Drug, Illness Rebound, FDA Report Says

J&J’s Experimental Dengue Drug Shows Promise In Early Research Involving Animals, Data Suggest

Mozambique Sees Record Increase In Cholera Cases As Malawi Sees Decline

Monoclonal Antibody Treatments Protective Against RSV Infection Among Vulnerable Infants, Meta-Analysis Indicates

President Biden Discusses Administration’s Plans To Lower Drug Costs

FDA Grants Pfizer’s Bivalent COVID-19 Vaccine Emergency Approval As Booster In Children Aged Six Months To Four Years

Russia’s Invasion Of Ukraine Worsens Spread Of HIV In Region, Studies Suggest

Malawi Faces Increased Risk Of Cholera Outbreak Following Heavy Rains From Cyclone

FDA Staff Say Trial Data Support Use Of Pfizer’s Nirmatrelvir/Ritonavir In Adults At High Risk For Severe COVID-19

Drug Developer Plans To Proceed With Late-Stage Trial Of COVID-19 Drug After FDA Declines Authorization

PEPFAR Has Delivered Treatment To Over 20 Million People With HIV Since Its Inception, Report Says